Melanoma is one type of skin cancer. It can happen anywhere on your body — including on the palms of the hands, bottoms of the feet and under the nails.
While it is not as common as other types of skin cancer (1% of skin cancers are melanoma) melanoma is more aggressive and is more likely to spread to other parts of the body, including the lymph nodes, lungs, liver, bones or brain. It can grow very quickly and, in the most advanced stage, become life-threatening in as little as six weeks. But melanoma is highly curable when discovered and treated in its earliest stages.
Can you survive melanoma?
All stages of melanoma are potentially survivable. The prognosis for survival is measured by the percentage of people alive after five years who have the same type and stage of melanoma. However, no two people are alike, and people have different responses to treatment. Overall, about 94% of people treated for melanoma are still alive five years after diagnosis (NCI SEER data, 2014-2020). That percentage varies by stage of melanoma:
- 100% survival for localized melanoma — The melanoma has not spread beyond the location where it started. About 77% of people are diagnosed at this stage.
- 74.8% survival for regional melanoma — The melanoma has spread to regional lymph nodes (nodes in the region around the tumor). About 10% of people are diagnosed at this stage.
- 35% survival for distant melanoma — The melanoma has metastasized or spread to other areas of the body. About 5% of people are diagnosed at this stage.
Doctors don’t usually say melanoma is curable, because there is a chance for any stage of melanoma — even melanoma treated at an early stage — to come back, known in medical terms as “recurrence.” If it comes back, it is most likely to happen within the first five years after treatment.
When melanoma does not come back within 10 years after treatment, it is less likely to return but there have been cases of melanoma returning even after 25 years. For this reason, it is vital to get regular check-ups and imaging scans as recommended by your doctor. You should also to do monthly skin self-checks. If you notice changes, call your doctor right away.
If you notice changes in existing moles or you develop new areas of skin that look unusual in color, shape, size or texture, it is important to contact your doctor right away.
Although melanoma can develop from a common mole, it is uncommon for it to do so. Melanoma begins in cells within the skin and eyes that produce melanin, which provides the pigment (color) of your eyes, hair and skin. The more melanin you produce, the darker your eyes, hair and skin. Genetics play a significant role in melanin production, as well, so it is possible to have dark eyes and hair while also having fair skin.
Causes of Melanoma
Ultraviolet light from the sun or tanning beds cause cancer by damaging our DNA. Your skin can repair the damage but over time, it becomes less able to do so, and changes can develop in skin cells that lead to melanoma.
It is rare to for melanoma to run in families, but some people can inherit genes that make them more likely to develop it.
Who Has the Greatest Risk of Developing Melanoma
It affects men and women but the incidence is different: Women are at higher risk before age 50, while men have a higher risk of developing the disease after age 50. Men are also more likely to die of melanoma than women. Another gender difference is where melanoma develops. In women, it is more often discovered on the back or lower legs. Men more typically get melanoma on the back, head or neck.
People with darker skin tones can develop melanoma and are more likely to be diagnosed with melanoma at later stages. It tends to develop underneath or around the nails, on the bottoms of the feet or on the palms of the hands. In these cases, it is unlikely to have developed from exposure to ultraviolet light.
Melanoma Risk Factors
- Frequent sun exposure without protecting your skin with clothing or sunscreen
- Using tanning equipment like tanning beds
- Blistering sunburns
- Fair skin
- Light-colored eyes
- Blond or red hair (naturally occurring)
- Weakened immune system
- Organ transplant recipient
Having certain types of cancer increase the risk of developing melanoma, such as a previous melanoma or other skin cancers).
What Melanoma Looks Like
Melanoma can appear as a change in how a mole you already have looks (increase in size, change in color, shape, feel) or it can be a new area on the skin that looks and feels different. When melanoma becomes advanced, it can bleed, itch become painful or look raw or scraped.
It may help to think of the features of melanoma as A, B, C, D and E:
- Asymmetry: One half doesn’t look the same as the other in shape
- Border: Border has ragged, uneven edges
- Color: Multiple colors, including black, brown, tan, white, gray, red, pink or blue
- Diameter: Melanomas can be very small or large, such as ¼ of an inch wide.
- Evolving: When a mole has changed over weeks or months, it could be melanoma
Diagnosing Melanoma Skin Cancer
If your doctor suspects you have melanoma, you will be referred to a dermatologist, who will examine your skin and look at it with specialized devices. If melanoma is suspected, the dermatologist will remove the abnormal area and a small amount of tissue around it, and send it to a lab. A pathologist will test the biopsied tissue to determine if it is melanoma. If it is, the pathologist will measure the depth of the invasion. Melanoma is staged based on the tumor’s thickness, and whether or not it has spread to the lymph nodes or other areas in the body.
Tissue samples may be tested for changes in specific genes, which can influence the type of treatment that will work best. The stage of the melanoma will also help determine treatment. Melanoma can be early stage — stage 0, is very superficial and not invasive. It can also be stage I, II, III or IV. Stages I and II are when the melanoma is still confined to just the one spot in the skin. Stage III is when the melanoma has spread to the local lymph nodes, and stage IV is when it has spread to other areas of the body.
If the melanoma is thicker and likely to spread, other tests are needed. These could include lymph node mapping, imaging scans and a blood test to check for an enzyme called lactate dehydrogenase or LDH.
Melanoma Skin Cancer Treatment
Even for the most advanced stages of melanoma, it is not too late to consider treatment. Depending on individual factors, it is possible to live for years after treatment. Radiation therapy, targeted therapy, immunotherapy and clinical trials can be used to treat melanoma that has spread throughout the body.
Your cancer team will recommend a treatment plan based on your cancer’s stage.
Surgery
Surgery is the first line of treatment for earlier stage melanoma and is performed by a surgical oncologist. It involves removing the melanoma, as well as a wide area of skin around the melanoma. If needed, skin is removed from another area of the body to cover the wound.
Depending on your cancer’s stage, your treatment team may recommend medications to eliminate any stray cancer cells left behind after surgery. Other treatments include:
Radiation Therapy
Radiation therapy shrinks tumors that have spread beyond the original site of the melanoma to other areas such as the brain, spinal cord, lungs or bones. It can also relieve symptoms caused by the melanoma. Sessions last 10 to 20 minutes, and the number of sessions you receive will depend on your tumor’s size and where it is in your body. As with radiation therapy for other types of cancer, there can be side effects including skin problems, fatigue, loss of hair and nausea. Tell your radiation oncologist right away if you are experiencing these side effects, as there are remedies to help.
Immunotherapy
Immunotherapy helps activate the immune system to find and eliminate cancer cells.
-
Checkpoint Inhibitors
Checkpoint inhibitors are a type of immunotherapy. Proteins called checkpoints on immune cells can be turned on or off to start an immune response. Some cancers have large amounts of checkpoint inhibitor proteins and can turn off checkpoints to hide from an immune system attack. Checkpoint inhibitors help the immune system find and destroy cancer.
Some common side effects can include loss of appetite, fatigue, nausea, skin rash. You may also develop painful joints, a cough or diarrhea. Serious side effects include autoimmune reactions, where the body attacks organs. These reactions can be life-threatening and require emergency treatment. You should tell your doctor immediately if you experience these problems, as treatment may need to stop. -
Interleukin-2 (IL-2)
Interleukin-2 (IL-2) is another type of immunotherapy that helps strengthen the immune system so it can better fight cancer. Given in a high dose, it can be used to treat patients with advanced melanoma.
Interleukins are proteins called cytokines that your cells already make. Cytokines bind to receptors found on the surface of immune cells. Essentially, they increase the immune system’s production of T-cells and natural killer cells. Both are types of white blood cells that fight any type of invader, like cancer, in the body.
The synthetic version of IL-2 (aldesleukin) is made in a lab. IL-2 can be used to treat advanced melanoma, although checkpoint inhibitors are used more because they are effective and tend to have fewer side effects. Due to the potential for serious side effects with IL-2, the risks and benefits are carefully evaluated before deciding on the treatment.
IL-2 is given as an IV injection for five days followed by a 14-day recovery period. After recovery, there is another five-day course of treatment. Patients receive IL-2 is in the hospital because they need their symptoms carefully monitored. Blood cell counts can become low, and there may be swelling in the body and flu-like symptoms (fever, chills, being drowsy or severely fatigued). It is important to receive IL-2 in a center that has experience with the treatment and navigating patients through its severe side effects.
-
Lifileucel
Lifileucel is the only FDA-approved tumor infiltrating lymphocyte (TIL) therapy for metastatic melanoma skin cancer and the first one-time cell therapy to treat solid tumor cancers. It is for certain people with advanced melanoma when their melanoma has gotten worse after treatment with an immune checkpoint inhibitor called anti-PD-1 or after treatment with targeted therapies. If you are relatively healthy with normal heart and lung function, your care team may consider you for lifileucel treatment.
The Clinical Cancer Center at Froedtert Hospital campus is currently the only facility in Wisconsin with the experience and certification to offer lifileucel treatment for advanced melanoma. Physicians at the Clinical Cancer Center participated in the clinical trial that eventually led to FDA approval of lifileucel.
Clinical trials testing lifileucel for melanoma have shown it to be effective in promoting overall survival. The median overall survival rate was 26 months; the two-year overall survival rate was about 54%.
How Lifileucel Works
TILs are specialized white blood cells that are a natural part of the immune system. They normally found within the tumor trying to eliminate cancer cells. When cancer cells grow and multiply, they can overcome TILs, keeping them from effectively performing their cancer-fighting role.
In TIL therapy, your care team sends a sample of tumor tissue to a lab, where TILs are separated out. They are mixed with IL-2 to stimulate their growth and activate them. The TILs are then cultured and multiplied. This process takes about 34 days. The result is a product called lifileucel, made up of billions of TILs. It is developed to work against a specific individual’s cancer cells.
After the lifileucel is available for your treatment, you will receive a high dose of chemotherapy that prepares the immune system to accept the new TILs instead of rejecting them. When infused back into the bloodstream, lifileucel finds cancer cells, recognizes them as abnormal and eliminates them.
Lifileucel is given as a single injection. After the dose of lifileucel, you will stay in the hospital for a few days to a week, where you receive six doses of IL-2 to make your immune system stronger and reinforce the effect of the new TILs.
The lifileucel treatment process, including the chemotherapy and IL-2, has side effects. Some side effects that are more serious than others are:
- Chills
- Fever
- Fatigue
- Tachycardia (Heart rate that is too fast)
- Diarrhea
- Fever with lowered white blood cell count
- Swelling in the body (most often in the legs and feet)
- Low blood pressure (hypotension) with a skin rash
- Alopecia (hair loss that is temporary or permanent)
- Infection
- Low levels of oxygen in the body (hypoxia)
- Shortness of breath
After finishing lifileucel treatment, it is important to stay within two hours travel time of the treatment location. Your care team will schedule frequent follow-up appointments to check if treatment is working and to help manage any side effects.
Targeted Therapy
Targeted therapy uses drugs or other agents to target specific molecules that cancer cells need to grow.
Vaccine Therapy
Vaccine therapy stimulates the immune system to attack invaders like cancer cells, bacteria or viruses.
Clinical Trials
Clinical trials may combine standard therapies with immunotherapies or targeted therapies. They are completely voluntary and, in some cases, clinical trials may be the best way to treat your melanoma. Ask your doctor if there is a clinical trial that could help you.
Virtual Visits Are Available
Safe and convenient virtual visits by video let you get the care you need via a mobile device, tablet or computer wherever you are. We’ll gather your medical records for you and get our experts’ input so we can offer treatment options without an in-person visit. To schedule a virtual visit, call 1-866-680-0505.